1
|
Ivanović J, Alfstad KÅ, Marthinsen PB, Olsen KB, Larsson PG, Pripp AH, Stanišić M. Seizure Outcome After Ipsitemporal Reoperation in Pharmacoresistant Temporal Lobe Epilepsy Patients With Hippocampal Sclerosis and Nonspecific Pathology. NEUROSURGERY OPEN 2021. [DOI: 10.1093/neuopn/okab001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
2
|
Sheikh SR, Nair D, Gross RE, Gonzalez‐Martinez J. Tracking a changing paradigm and the modern face of epilepsy surgery: A comprehensive and critical review on the hunt for the optimal extent of resection in mesial temporal lobe epilepsy. Epilepsia 2019; 60:1768-1793. [DOI: 10.1111/epi.16310] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Revised: 07/13/2019] [Accepted: 07/14/2019] [Indexed: 11/30/2022]
Affiliation(s)
- Shehryar R. Sheikh
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Ohio
| | - Dileep Nair
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Ohio
- Epilepsy Center Cleveland Clinic Foundation Cleveland Ohio
| | | | - Jorge Gonzalez‐Martinez
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Ohio
- Epilepsy Center Cleveland Clinic Foundation Cleveland Ohio
- Department of Neurosurgery Cleveland Clinic Foundation Cleveland Ohio
| |
Collapse
|
3
|
Cahill V, Sinclair B, Malpas CB, McIntosh AM, Chen Z, Vivash LE, O'Shea MF, Wilson SJ, Desmond PM, Berlangieri SU, Hicks RJ, Rowe CC, Morokoff AP, King JA, Fabinyi GC, Kaye AH, Kwan P, Berkovic SF, O'Brien TJ. Metabolic patterns and seizure outcomes following anterior temporal lobectomy. Ann Neurol 2019; 85:241-250. [DOI: 10.1002/ana.25405] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Revised: 12/22/2018] [Accepted: 12/24/2018] [Indexed: 01/21/2023]
Affiliation(s)
- Varduhi Cahill
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Manchester Centre for Clinical Neurosciences; Salford Royal NHS Foundation Trust; Salford United Kingdom
- Division of Neuroscience and Experimental Psychology; School of Biological Sciences, University of Manchester; Manchester United Kingdom
| | - Benjamin Sinclair
- Departments of Medicine and Radiology; University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
| | - Charles B. Malpas
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
- Murdoch Children's Research Institute; Melbourne Victoria Australia
- Melbourne School of Psychological Sciences; University of Melbourne; Melbourne Victoria Australia
| | - Anne M. McIntosh
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
- Epilepsy Research Centre; University of Melbourne, Austin Hospital; Melbourne Victoria Australia
| | - Zhibin Chen
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
| | - Lucy E. Vivash
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
| | - Marie F. O'Shea
- Comprehensive Epilepsy Program; Austin Hospital; Melbourne Victoria Australia
| | - Sarah J. Wilson
- Melbourne School of Psychological Sciences; University of Melbourne; Melbourne Victoria Australia
- Comprehensive Epilepsy Program; Austin Hospital; Melbourne Victoria Australia
| | - Patricia M. Desmond
- Departments of Medicine and Radiology; University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
| | | | - Rodney J. Hicks
- Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology; University of Melbourne; Melbourne Victoria Australia
| | - Christopher C. Rowe
- Epilepsy Research Centre; University of Melbourne, Austin Hospital; Melbourne Victoria Australia
- Florey Institute of Neuroscience and Mental Health; University of Melbourne; Melbourne Victoria Australia
| | - Andrew P. Morokoff
- Department of Surgery; University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
| | - James A. King
- Department of Surgery; University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
| | - Gavin C. Fabinyi
- Department of Surgery; University of Melbourne, Austin Hospital; Melbourne Victoria Australia
| | - Andrew H. Kaye
- Department of Surgery; University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
| | - Patrick Kwan
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
| | - Samuel F. Berkovic
- Epilepsy Research Centre; University of Melbourne, Austin Hospital; Melbourne Victoria Australia
- Comprehensive Epilepsy Program; Austin Hospital; Melbourne Victoria Australia
| | - Terence J. O'Brien
- Departments of Medicine and Neurology; Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital; Melbourne Victoria Australia
- Departments of Neuroscience and Neurology; Alfred Health, Central Clinical School, Monash University; Melbourne Victoria Australia
| |
Collapse
|
4
|
De Blasi B, Barnes A, Galazzo IB, Hua CH, Shulkin B, Koepp M, Tisdall M. Age-Specific 18F-FDG Image Processing Pipelines and Analysis Are Essential for Individual Mapping of Seizure Foci in Pediatric Patients with Intractable Epilepsy. J Nucl Med 2018; 59:1590-1596. [PMID: 29626122 PMCID: PMC6167536 DOI: 10.2967/jnumed.117.203950] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Accepted: 02/03/2018] [Indexed: 12/05/2022] Open
Abstract
18F-FDG PET is an important tool for the presurgical assessment of children with drug-resistant epilepsy. Standard assessment is performed visually and is often subjective and highly user-dependent. Voxelwise statistics can be used to remove user-dependent biases by automatically identifying areas of significant hypo- or hypermetabolism associated with the epileptogenic area. In the clinical setting, this analysis is performed using commercially available software. These software packages suffer from two main limitations when applied to pediatric PET data: pediatric scans are spatially normalized to an adult standard template, and statistical comparisons use an adult control dataset. The aim of this work was to provide a reliable observer-independent pipeline for the analysis of pediatric 18F-FDG PET scans, as part of presurgical planning in epilepsy. Methods: A pseudocontrol dataset (19 subjects 6–9 y old, and 93 subjects 10–20 y old) was used to create two age-specific 18F-FDG PET pediatric templates in standard pediatric space. The 18F-FDG PET scans of 46 epilepsy patients (16 patients 6–9 y old, and 30 patients 10–17 y old) were retrospectively collated and analyzed using voxelwise statistics. This procedure was implemented with the standard pipeline available in the commercial software Scenium and an in-house Statistical Parametric Mapping, version 8 (SPM8), pipeline (including age-specific pediatric templates and reference database). A κ-test was used to assess the level of agreement between the findings of voxelwise analyses and the clinical diagnosis of each patient. The SPM8 pipeline was further validated using postsurgical seizure-free patients. Results: Improved agreement with the clinical diagnosis was reported using SPM8, in terms of focus localization, especially for the younger patient group: κ = 0.489 for Scenium versus 0.826 for SPM. The proposed pipeline also showed a sensitivity of about 70% in both age ranges for the localization of hypometabolic areas on pediatric 18F-FDG PET scans in postsurgical seizure-free patients. Conclusion: We showed that by creating age-specific templates and using pediatric control databases, our pipeline provides an accurate and sensitive semiquantitative method for assessing the 18F-FDG PET scans of patients under 18 y old.
Collapse
Affiliation(s)
- Bianca De Blasi
- Department of Medical Physics, University College London, London, United Kingdom
| | - Anna Barnes
- Institute of Nuclear Medicine, University College London Hospitals, London, United Kingdom
| | | | - Chia-Ho Hua
- Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee
| | - Barry Shulkin
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee
| | - Matthias Koepp
- Institute of Neurology, University College London, London, United Kingdom; and
| | | |
Collapse
|
5
|
The Value of Regional Cerebral Blood Flow SPECT and FDG PET in Operculoinsular Epilepsy. Clin Nucl Med 2018; 43:e67-e73. [DOI: 10.1097/rlu.0000000000001949] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
6
|
Ivanovic J, Larsson PG, Østby Y, Hald J, Krossnes BK, Fjeld JG, Pripp AH, Alfstad KÅ, Egge A, Stanisic M. Seizure outcomes of temporal lobe epilepsy surgery in patients with normal MRI and without specific histopathology. Acta Neurochir (Wien) 2017; 159:757-766. [PMID: 28281007 PMCID: PMC5385196 DOI: 10.1007/s00701-017-3127-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Accepted: 02/16/2017] [Indexed: 12/02/2022]
Abstract
BACKGROUND Seizure outcome following surgery in pharmacoresistant temporal lobe epilepsy patients with normal magnetic resonance imaging and normal or non-specific histopathology is not sufficiently presented in the literature. METHODS In a retrospective design, we reviewed data of 263 patients who had undergone temporal lobe epilepsy surgery and identified 26 (9.9%) who met the inclusion criteria. Seizure outcomes were determined at 2-year follow-up. Potential predictors of Engel class I (satisfactory outcome) were identified by logistic regression analyses. RESULTS Engel class I outcome was achieved in 61.5% of patients, 50% being completely seizure free (Engel class IA outcome). The strongest predictors of satisfactory outcome were typical ictal seizure semiology (p = 0.048) and localised ictal discharges on scalp EEG (p = 0.036). CONCLUSION Surgery might be an effective treatment choice for the majority of these patients, although outcomes are less favourable than in patients with magnetic resonance imaging-defined lesional temporal lobe epilepsy. Typical ictal seizure semiology and localised ictal discharges on scalp EEG were predictors of Engel class I outcome.
Collapse
Affiliation(s)
- Jugoslav Ivanovic
- Department of Neurosurgery, Oslo University Hospital, Sognsvannsveien 20, N-0027, Oslo, Norway.
| | - Pål G Larsson
- Clinical Neurophysiologic Laboratory, Department of Neurosurgery, Oslo University Hospital, Oslo, Norway
| | - Ylva Østby
- Department of Clinical Psychology and Neuropsychology, National Centre for Epilepsy, Oslo University Hospital, Oslo, Norway
| | - John Hald
- Department of Radiology, Oslo University Hospital, Oslo, Norway
| | - Bård K Krossnes
- Department of Pathology, Oslo University Hospital, Oslo, Norway
| | - Jan G Fjeld
- Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway
- Oslo and Akershus University College of Applied Sciences, Oslo, Norway
| | - Are H Pripp
- Oslo Centre for Biostatistics and Epidemiology, Research Support Service, Oslo University Hospital, Oslo, Norway
| | - Kristin Å Alfstad
- Department of Adult Epilepsy, National Centre for Epilepsy, Oslo University Hospital, Oslo, Norway
| | - Arild Egge
- Department of Neurosurgery, Oslo University Hospital, Sognsvannsveien 20, N-0027, Oslo, Norway
| | - Milo Stanisic
- Department of Neurosurgery, Oslo University Hospital, Sognsvannsveien 20, N-0027, Oslo, Norway
| |
Collapse
|
7
|
|